section name header

Basics

Description
Epidemiology

Prevalence

  • Approximately 1 in 5 adult Americans currently smoke.
  • Higher in men (23.9%) than women (18%)

Morbidity

Smoking has adverse effects on every organ system in the body and reduces health in general. It impairs physical fitness, endurance, and general well-being.

Mortality

Approximately 1 in every 5 deaths each year (443,000 deaths) is attributed to either direct or indirect effects of smoking. More deaths are caused by smoking than that of HIV, illegal drug use, alcohol behavior, and motor vehicle accidents combined.

Etiology/Risk Factors
Physiology/Pathophysiology

Nicotine stimulates preganglionic autonomic receptors, resulting in the release of epinephrine from adrenal glands, norepinephrine from nerve endings, and dopamine and endorphins from the central nervous system. They are responsible for different perceptions and behaviors, including the euphoria associated with smoking. Hence, it is a highly addictive substance.

Anesthetic GOALS/GUIDING Principles

Smoking cessation: Ideally smoking should be stopped 8 weeks prior to surgery (patients should be advised at the surgeon's office or at the time of scheduling). If that does not occur or the patient is unable to stop, abstinence should be recommended for at least 24 hours prior to surgery, or the evening before surgery to decrease the deleterious effects of nicotine and carbon monoxide.

Diagnosis

Symptoms

COPD and cardiovascular symptomatology should be sought.

History

  • Pack year history
  • Respiratory: Infections, recent COPD exacerbations, dyspnea, increased fatigability.
  • Cardiovascular: Evidence of coronary artery disease (CAD) (e.g., previous MI and chest pain) and peripheral vascular disease (e.g., claudication and rest pain).

Signs/Physical Exam

Respiratory and cardiovascular symptomatology should be sought.

Treatment History

Counseling

Medications
Diagnostic Tests & Interpretation

Labs/Studies

  • Pulmonary function tests (PFTs) would demonstrate an obstructive pattern (decrease in FEV1 that is greater than the decrease in FVC, and a decreased FEV1/FVC ratio).
  • Arterial blood gas can show hypoxia, hypercapnia
  • Co-oximetry can measure carbon monoxide levels
CONCOMITANT ORGAN DYSFUNCTION
Circumstances to delay/Conditions

Acute COPD exacerbation

Treatment

PREOPERATIVE PREPARATION

Premedications

  • Anxiolytic medications can reduce the psychological effects of smoking cessation.
  • Bronchodilators in patients who show a reversible bronchospastic component to their reactive airway disease.
  • Antibiotics in those who have active respiratory tract infections.
  • Pulmonary toilet. Humidification and chest physical therapy to improve secretion clearance; incentive spirometry education.
  • Steroids may be considered in patients with moderate-to-severe reversible airway disease; however, their effects are not immediate and need to be weighed against potential risks.
INTRAOPERATIVE CARE

Choice of Anesthesia

  • Local or regional anesthesia are often preferable to general anesthesia (avoids airway manipulation, positive pressure ventilation, and unpredictable interactions with opioids).
  • Neuraxial techniques for surgical anesthesia. Motor blockade above the T10 level can markedly decrease the forced expiratory flow in patients with impaired pulmonary function.
  • Epidural analgesia for postoperative pain can facilitate deep breathing and coughing and improves respiratory care.

Monitors

  • Pulse oximetry: Beware of overestimation of oxygen saturation due to the presence of carboxyhemoglobin. May require pulse oximetry with multiple wavelengths to attain accurate readings.
  • Electrocardiogram with ST segment analysis can help detect myocardial ischemia.
  • Arterial line. In major surgeries, especially neurosurgical cases, paCO2 measurements are highly recommended to estimate the paCO2 – EtCO2 gradient (smokers have elevated gradients).

Induction/Airway Management

  • Preoxygenation (denitrogenation) with 100% oxygen can negate the effects of increased closing capacity and carbon monoxide levels.
  • Any IV induction agent at adequate dosages is satisfactory. Although thiopental does not cause bronchospasm, it does not blunt reactivity.
  • IV lidocaine is useful during induction to decrease airway reactivity to intubation, or, alternatively, one can spray lidocaine on the vocal cords before intubation.
  • Airway manipulation and surgical stimulation should be avoided during the "excitatory stages" of anesthesia to decrease the incidence of respiratory-related adverse events.

Maintenance

  • Volatile agents are preferred due to their salutary effects on bronchial reactivity. Avoid introduction of high concentrations of desflurane during induction to prevent breathholding and laryngospasm. Desflurane stimulates respiratory irritant receptors in chronic smokers and thereby the sympathoadrenal system, resulting in higher BPs and tachycardia. Nitrous oxide is not contraindicated in patients without bullous emphysema; however, underlying respiratory pathology may decrease the patient's ability to tolerate decreased FiO2.
  • Neuromuscular blockade. If utilized, neuromuscular monitoring is mandatory for the titration of muscle relaxants. Nicotine stimulates nicotinic acetyl cholinergic receptors in small plasma concentrations resulting in increased requirement of muscle relaxants to induce and maintain neuromuscular blockade. This effect, however, is not uniform among all muscle relaxants. Monitoring will help to prevent bucking and bronchospasm during maintenance.

Extubation/Emergence

  • Extubation in the excitatory stage of anesthesia can result in laryngospasm, bronchospasm, and breath holding. Consider a "deep extubation," if appropriate.
  • Nicotine may have antinociceptive effects and decrease the incidence of nausea and vomiting. However, prophylactic antiemetics should still be considered.

Follow-Up

Bed Acuity

Dependent on surgical procedure, intraoperative events, and the need for postoperative intubation and mechanical ventilation

Medications/Lab Studies/Consults
Complications

Nicotine withdrawal, inadequate pain control, poor wound healing, DVT, PPC

References

  1. CDC . Cigarette smoking among adults – United States, 2006. MMWR. 2007;56:11571161.
  2. Turan A , Mascha EJ , Roberman D , et al. Smoking and perioperative outcomes. Anesthesiology. 2011.
  3. Warner DO. Perioperative abstinence from cigarettes: Physiologic and clinical consequences. Anesthesiology. 2006;104:356667.

Additional Reading

See Also (Topic, Algorithm, Electronic Media Element)

Codes

ICD9

305.1 Tobacco use disorder

ICD10

Z72.0 Tobacco use

Clinical Pearls

Author(s)

Jagan Devarajan , MD, FRCA

Beth H. Minzter , MD, MS, FIPP